Evidence map›Paper›PMID 24349085›Full record

ArticlePloS one2013

Transglutaminase 2 contributes to apoptosis induction in Jurkat T cells by modulating Ca2+ homeostasis via cross-linking RAP1GDS1.

Yu-Fan Hsieh, Guang-Yaw Liu, Yi-Ju Lee, Jiann-Jou Yang, Katalin Sándor, Zsolt Sarang, Angela Bononi, Paolo Pinton, László Tretter, Zsuzsa Szondy and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.International journal of molecular medicine · 2018
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Yu-Fan HsiehInstitute of Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan.
Guang-Yaw LiuInstitute of Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan.
Yi-Ju LeeInstitute of Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan.
Jiann-Jou YangDepartment of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan.
Katalin SándorDepartment of Biochemistry and Molecular Biology, Research Center of Molecular Medicine, University of Debrecen, Debrecen, Hungary.
Zsolt SarangDepartment of Biochemistry and Molecular Biology, Research Center of Molecular Medicine, University of Debrecen, Debrecen, Hungary.
Angela BononiDepartment of Experimental and Diagnostic Medicine, Section of General Pathology, Interdisciplinary Center for the Study of Inflammation (ICSI), Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.
Paolo PintonDepartment of Experimental and Diagnostic Medicine, Section of General Pathology, Interdisciplinary Center for the Study of Inflammation (ICSI), Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.
László TretterDepartment of Medical Biochemistry, Semmelweis University, Neurobiochemical Group of Hungarian Academy of Sciences, Budapest, Hungary.
Zsuzsa SzondyDepartment of Biochemistry and Molecular Biology, Research Center of Molecular Medicine, University of Debrecen, Debrecen, Hungary.
Gregory J TsayInstitute of Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan ; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Chung Shan Medical University · TWUniversity of Debrecen · HUUniversity of Ferrara · ITHungarian Academy of Sciences · HU

Funding

Telethon GGP09128Telethon GGP11139
6 · The paper itself

Abstract

backgroundTransglutaminase 2 (TG2) is a protein cross-linking enzyme known to be associated with the in vivo apoptosis program of T cells. However, its role in the T cell apoptosis program was not investigated yet.

resultsHere we report that timed overexpression of both the wild type (wt) and the cross-linking mutant of TG2 induced apoptosis in Jurkat T cells, the wt being more effective. Part of TG2 colocalised with mitochondria. WtTG2-induced apoptosis was characterized by enhanced mitochondrial Ca(2+) uptake. Ca(2+)-activated wtTG2 cross-linked RAP1, GTP-GDP dissociation stimulator 1, an unusual guanine exchange factor acting on various small GTPases, to induce a yet uncharacterized signaling pathway that was able to promote the Ca(2+) release from the endoplasmic reticulum via both Ins3P and ryanodine sensitive receptors leading to a consequently enhanced mitochondrial Ca(2+)uptake.

conclusionsOur data indicate that TG2 might act as a Ca(2+) sensor to amplify endoplasmic reticulum-derived Ca(2+) signals to enhance mitochondria Ca(2+) uptake. Since enhanced mitochondrial Ca(2+) levels were previously shown to sensitize mitochondria for various apoptotic signals, our data demonstrate a novel mechanism through which TG2 can contribute to the induction of apoptosis in certain cell types. Since, as compared to knock out cells, physiological levels of TG2 affected Ca(2+) signals in mouse embryonic fibroblasts similar to Jurkat cells, our data might indicate a more general role of TG2 in the regulation of mitochondrial Ca(2+) homeostasis.

Indexed as

Calcium SignalingAnimalsApoptosisCalciumCell LineEndoplasmic ReticulumFibroblastsGene Expression RegulationGTP-Binding ProteinsGuanine Nucleotide Exchange FactorsHomeostasisHumansInositol PhosphatesIon TransportJurkat CellsMiceCalciumGTP-Binding ProteinsGuanine Nucleotide Exchange Factorsinositol 3-phosphateInositol PhosphatesProtein Glutamine gamma Glutamyltransferase 2RAP1GDS1 protein, humanRyanodine Receptor Calcium Release ChannelTransglutaminases

Identifiers

PMID24349085
PMCPMC3859493
OpenAlexW2054544716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.